We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Co-Diagnostics, Inc.

Co-Diagnostics, Inc. is a molecular diagnostics company that develops, manufactures and markets a new, state-of-the-a... read more Featured Products: More products

Download Mobile App





Co-Diagnostics Introduces Co-Dx PCR Platform and Co-Primers Technology

By LabMedica International staff writers
Posted on 11 Nov 2024

Co-Diagnostics (Salt Lake City, UT, USA), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, is hosting a booth and delivering a presentation at the MEDICA 2024 trade fair in Düsseldorf. More...

MEDICA has become the world's largest medical B2B trade fair, attracting 83,000 visitors and over 5,300 exhibitors from almost 70 countries. The company aims to use the opportunity to generate increased interest in its suite of PCR in vitro diagnostic and research products for infectious diseases and to introduce and promote its Co-Primers technology and applications to a wide audience of international attendees.

Co-Primers by Co-Diagnostics is a new class of primer technology that uses a novel architecture to help combat some common issues that can plague multiplex PCR. The unique Co-Primers design reduces primer dimer propagation. Co-Primers technology includes the use of cooperative primers sometimes in combination with other types of primers or probe designs, and is the first PCR technology of its kind to help prevent primer dimer propagation during nucleic acid amplification. In multiplexed reactions where large numbers of primers increase the probability of primer dimer formation, enhanced specificity is particularly important. In a traditional primer process, a pair of primers hybridizes with the sample DNA or RNA sequence and defines the region that will be amplified. In a Co-Primers process, the PCR primer is divided into two segments separated by a PEG (polyethylene glycol) linker. Both the capture sequence and the priming sequence must cooperate to bind to the DNA or RNA target to amplify the intended region. Primer dimers are not propagated because they cannot hybridize to the capture region.

The company's presentation on its upcoming Co-Dx PCR platform is titled "Advancing POC/OTC Diagnostics: Innovations in Test Development for the Co-Dx PCR Platform". The Co-Dx PCR testing platform aims to provide accessible, affordable PCR testing for all, transforming healthcare delivery and creating a positive impact on a global scale by democratizing access to molecular diagnostics. The instrument with dimensions of 6 ½” x 4 1/2” x 6” and weighing two pounds operates via a smartphone app with simple-to-follow instructions that include videos to walk users through every step, some sample swab collection to the straightforward instrument operation. Results are processed in the cloud and delivered back to the user’s smartphone or tablet in about 30 minutes using software designed from the ground up for this specific use. The PCR tests themselves (contained in the simple but unique, innovative test collection cups) are powered by Co-Primers PCR technology.

Related Links:
Co-Diagnostics


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The Elecsys pTau-181 test helps rule out Alzheimer’s disease in symptomatic patients aged 55 and older by identifying absence of amyloid pathology (photo courtesy of Roche)

Simple Blood Test Offers New Path to Alzheimer’s Assessment in Primary Care

Timely evaluation of cognitive symptoms in primary care is often limited by restricted access to specialized diagnostics and invasive confirmatory procedures. Clinicians need accessible tools to determine... Read more

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Pathology

view channel
Image: The innovative classifier can guide treatment for PDAC and other immunotherapy-resistant cancers (Photo courtesy of Adobe Stock))

Single Sample Classifier Predicts Cancer-Associated Fibroblast Subtypes in Patient Samples

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, in part because of its dense tumor microenvironment that influences how tumors grow and respond to treatment.... Read more

Industry

view channel
Image: QuidelOrtho has entered into a strategic supply agreement with Lifotronic to expand its global immunoassay portfolio (Photo courtesy of QuidelOrtho)

QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio

QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.